Inspira Technologies Oxy B.H.N. Ltd IINN

NAS: IINN | ISIN: IL0011715781   17/05/2024
2,300 USD (-0,43%)
(-0,43%)   17/05/2024

2 mei 2024 · Inspira™ Announces Start of Production of the INSPIRA™ ART100 · Persbericht

25 april 2024 · Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100 · Persbericht

16 april 2024 · Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures · Persbericht

10 april 2024 · Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections · Persbericht

3 april 2024 · Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb · Persbericht

1 april 2024 · Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager · Persbericht

25 maart 2024 · Inspira™ Technologies Reports Full Year 2023 Financial Results · Persbericht

18 maart 2024 · Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets · Persbericht

12 maart 2024 · Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator · Persbericht

4 maart 2024 · Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days · Persbericht

27 februari 2024 · Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone · Persbericht

27 februari 2024 · Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements · Persbericht

22 februari 2024 · Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies · Persbericht

14 februari 2024 · Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System · Persbericht

8 februari 2024 · Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device · Persbericht

30 januari 2024 · Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices · Persbericht

9 januari 2024 · Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity · Persbericht

2 januari 2024 · Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device · Persbericht

28 december 2023 · Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering · Persbericht

26 december 2023 · Inspira Announces $3.88 Million Registered Direct Offering · Persbericht

Mijn selecties